08.06.2012
- Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...
07.06.2012
- Pfizer plans to separate its animal health unit into a standalone company, a move Wall Street expected as the largest U.S. drugmaker focuses more intently on its core...
02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
01.06.2012
- Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...
28.05.2012
- Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...
25.05.2012
- Takeda Pharmaceutical, Japan's top drugmaker, is to buy Brazil's Multilab for up to 540 million Brazilian reals ($265 million) in a deal highlighting global drugmakers' appetite...
22.05.2012
- Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains made in the fight against the disease in the...
10.05.2012
- GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the...
28.04.2012
- French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
